Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00967837 · ClinicalTrials.gov registry record · Phase 2
Effects of Pulsatile Intravenous (IV) Insulin on Wound Healing in Diabetics
A Phase 2 study, sponsored by Florida Atlantic University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 152
- Enrollment target
NCT00967837 is a Phase 2 study that was terminated before completion, run by Florida Atlantic University. The registered enrollment target is 152 participants.
The verdict
NCT00967837, a Phase 2 study, was terminated before completion, sponsored by Florida Atlantic University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 152 participants
- Enrollment target
Study Summary
One of the significant complications associated with some patients with diabetes is the inability for wounds to heal regardless of enrolling and participating in a traditional wound healing program. There have been a number of anecdotal evidence presented by patients receiving pulsatile intravenous insulin therapy for other complications with non healing wounds lasting from several months to several years whose wounds healed while receiving therapy. This study was designed to specifically monitor the progress of diabetic patients who have failed traditional wound care therapy and monitor the progress of their wounds while receiving pulsatile intravenous insulin therapy.
Interventions
- PROCEDURE Pulsatile Intravenous Insulin Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 152 participants |
| Start Date | 2006-01 |
| Est. Completion | 2012-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00967837
The ClinicalTrials.gov registry entry for NCT00967837 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 152 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Florida Atlantic University, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pulsatile Intravenous Insulin Therapy is the first listed.
NCT00967837 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00967837 about?
NCT00967837 is a clinical study titled "Effects of Pulsatile Intravenous (IV) Insulin on Wound Healing in Diabetics". One of the significant complications associated with some patients with diabetes is the inability for wounds to heal regardless of enrolling and participating in a traditional wound healing program. There have been a number of anecdotal evidence presented by patients receiving pulsatile intravenous ...
What is the current status of trial NCT00967837?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 152 participants. The study started on 2006-01. Estimated completion is 2012-09.
What interventions are being tested in trial NCT00967837?
The interventions under investigation include: Pulsatile Intravenous Insulin Therapy (PROCEDURE).
Who is sponsoring clinical trial NCT00967837?
This trial is sponsored by Florida Atlantic University, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.